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Background: The open abdomen (OA) is an important approach for managing
intra-abdominal catastrophes and continues to be the standard of care. Complete fascial
closure is an essential treatment objective and can be achieved by the use of different
dynamic closure techniques. Both surgical technique and—decisionmaking are essential
for optimal patient outcome in terms of fascial closure. The aim of this study was
to analyse patients’ outcome after the use of mesh-mediated fascial traction (MMFT)
associated with negative pressure wound therapy (NPWT) and identify important factors
that negatively influenced final fascial closure.
Methods: A single center ambispective analysis was performed including all patients
treated for an open abdomen in a tertiary referral center from 3/2011 till 2/2020. All
patients with a minimum survival >24 h after initiation of treatment were analyzed. The
data concerning patient management was collected and entered into the Open Abdomen
Route of the European Hernia Society (EHS). Patient basic characteristics considering
OA indication, primary fascial closure, as well as important features in surgical technique
including time after index procedure to start mesh mediated fascial traction, surgical
closure techniques and patients’ long-term outcomes were analyzed.
Results: Data were obtained from 152 patients who underwent open abdomen therapy
(OAT) in a single center study. Indications for OAT as per-protocol analysis were sepsis
(33.3%), abdominal compartment syndrome (31.6%), followed by peritonitis (24.2%),
abdominal trauma (8.3%) and burst abdomen (2.4%). Overall fascial closure rate was
80% as in the per-protocol analysis. When patients that started OA management with
MMFT and NPWT from the initial surgery a significantly better fascial closure rate was
achieved compared to patients that started 3 or more days later (p< 0.001). An incisional
hernia developed in 35.8% of patients alive with a median follow-up of 49 months (range
6–96 months).
Conclusion: Our main findings emphasize the importance of a standardized treatment
plan, initiated early on during management of the OA. The use of vacuum assisted
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closure in combination with MMFT showed high rates of fascial closure. Absence of initial
intraperitoneal NPWT as well as delayed start of MMFT were risk factors for non-fascial
closure. Initiation of OA with VACM should not be unnecessary delayed.
Keywords: open abdomen, dynamic closure, negative pressure therapy, fascial closure, abdominal compartment
syndrome, mesh mediated fascial traction
INTRODUCTION
Open abdomen (OA) is a well-known clinical entity. It leaves a
laparotomy incision without closure and is to be distinguished
from “burst abdomen”, which is an unintended fascial dehiscence
after primary closure of a laparotomy incision. Its objective
is to temporarily close the abdomen in a tension-free manner
and to allow second-look operations. This surgical strategy
is now used for managing different pathologies, e.g., intra-
abdominal hypertension, sepsis, trauma or staged abdominal
wall repair (1). Although this procedure is potentially life-
saving, it is also associated with a number of complications
and with a high mortality (2, 3). In order to reduce both the
complications associated with open abdomen and to improve
fascial closure rates, the preferred method of approach now
focusses on early closure of the abdomen, preferably within the
first 10–14 days (4). There have been several ways of temporary
abdominal wall closure (TAC) which help closing the fascia.
However, little is known about reasons for non-fascial closure
at the end of open abdomen treatment (1, 5). Early planning
and an upfront surgical strategy are key-elements. In relation
to the overall outcome of an open abdomen treatment, the
classification scheme reported and amended by Björk et al.
correlates with prognosis and is very helpful in determining both
fascial closure rate as well as overall morbidity and mortality
(6, 7). An important distinction should be made between the so-
called static and dynamic closing techniques. The combination of
negative-pressure wound therapy (NPWT) and mesh-mediated
fascial traction (MMFT) or NPWT and dynamic fascial sutures
(DFS) is associated with highest fascial closure rates (8–10). The
purpose is to establish edema reduction in combination with
fascial reapproximation (11–13).
Currently, vacuum assisted closure (VAC) in combination
with MMFT (VACM) represents the current gold standard with
fascial closure rates of up to 90% and is acknowledged to be
superior to other techniques lacking mechanical fascial traction
(14–17). Recently, the European Hernia Society (EHS) published
clinical guidelines on the management of the open abdomen and
clearly recommended dynamic closure techniques, with 75.9 vs.
33.9% fascial closure rate compared to the results of static closure
techniques (18). The aim of this analysis is to evaluate patient
outcome after VACMand to determine crucial factors for optimal
treatment, regarding both timing and surgical technique.
MATERIALS AND METHODS
Study Population and Study Design
From 3/2011 till 2/2020, all patients treated with intraperitoneal
NPWT at our tertiary referral hospital were both retrospectively
and prospectively entered into the Open Abdomen Route of
the European Registry of Abdominal Wall Hernias (EuraHS—
www.eurahs.eu) (19, 20). As the Open abdomen Route only
became available in 2015 all data that was already gathered before
was retrospectively entered in EuraHS. Approval of the Medical
Ethics Committee was obtained prior to this study.
All files of patients whom underwent VACM at our
hospital in this period were retrospectively analyzed. Patients
with NPWT without MMFT and patients with only use of
MMFT were excluded. Patients who died within 24 h after
initiation of open abdomen treatment were also excluded.
Variables on every patient and course of treatment were
registered including underlying conditions and comorbidities,
open abdomen management, clinical course, and clinical follow-
up assessments.
VACM Protocol
A standardized protocol was used in all cases as previously
described by Petersson et al. (21). At time of initial surgery
an intraperitoneal NPWT device was placed when no new
anastomosis, bile leak or active bleeding was present. This
abdominal dressing (ABTheraTM Open Abdomen Negative
Pressure Therapy System, KCI, San Antonio, TX) consists of an
elliptical shaped perforated polyurethane foam encapsulated in
a visceral protective layer, designed to be wrapped around the
viscera. It’s mandatory for the device to be placed deep in the
paracolic gutters and Douglas space, in order to evacuate as much
liquid as possible and to avoid formation of adhesions.
In other cases a plain plastic sheet was used as a visceral
protective layer. On top of the visceral protective layer a
heavyweight mesh is sewn in with a continuous non-resorbable
monofilament 2/0 suture at the fascial edges. Strong traction
on this mesh is then applied. The mesh is then covered by a
macroporous oval shaped foam dressing and protected by an
adhesive sheet with attachment of the suction pad and connected
to a canister. Suction was applied at−125mm Hg (Figure 1).
Outcome Variables
Our primary outcome was delayed primary fascial closure, i.e.,
the fascial edges completely sutured together with no remaining
fascial defect.
Patient Characteristics
The Open Abdomen Route covers many variables on every
patient and course of treatment and is divided into various
categories providing information on the patient, underlying
conditions and comorbidities, open abdomen management,
clinical course, and clinical follow-up assessments.
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FIGURE 1 | Technique of vacuum assisted mesh mediated fascial traction.
Sex, BodyMass Index (BMI), age at time of surgery, indication
for OA therapy, time between initial surgery and start of VACM,
duration of VACM, complications and patient mortality were
variables chosen for analysis based on their clinical relevance
in regard to open abdomen management. Classification of the
open abdomen was based on Björck’s classification published in
2009 (7).
Follow-up was performed by chart-review at the time of
analysis and in case patients were still alive a clinical examination
was performed to evaluate incisional hernia formation.
Statistical Analysis
A descriptive analysis was performed on the different targets
of the VACM protocol and patient-related factors. Statistical
analysis was performed using SPSS (version 25.0) software.
Normally distributed variables were presented as means ±
standard deviations. Non-normally distributed variables were
presented as medians and 95% confidence intervals (CIs).
Depending on the distribution and the level of measurement,
univariate analyses were performed using Fisher’s exact test, chi-
squared test or Mann-Whitney U test. The significance threshold
was set at p= 0.05.
RESULTS
Patient Characteristics of the Complete
Study Cohort
Between 08/03/2011 and 20/02/2020 152 patients underwent an
open abdomen treatment using VACM. Thirty-two patients were
excluded for final analysis of the primary endpoint because they
died before final closure of the abdomen or within 24 h after
closing the abdomen (9).
The mean age of the patients was 58 years. Sixty-eight percent
were male. The mean BMI was 26.0 at the initiation of open
abdomenmanagement. Overall hospital mortality was 21% (32 of
152 patients). Baseline characteristics and risk factors regarding
abdominal wall closure and wound healing are depicted in
Table 1.
Patients Completing the Open Abdomen
Treatment
Indications were noted as sepsis in 40 patients (33.3%),
abdominal compartment syndrome in 38 (31.6%), peritonitis in
29 (24.2%), trauma in 10 (8.3%), and burst abdomen in three
patients (2.5%).
Frontiers in Surgery | www.frontiersin.org 3 February 2021 | Volume 7 | Article 606539
Berrevoet et al. Early Treatment Initiation Is Essential
TABLE 1 | Patients characteristics.
Number of patients 152
Age (years) 57.53 ± 16.3
Gender (female/male) 82 (68.3%)/38 (31.7%)
Body mass index (BMI) 26.15 ± 5.9
Malignancy 18 (15%)
Diabetes 19 (15.8%)
Cardiopulmonary disease 32 (26.7%)
Immunosuppression 7 (5.8%)
Mannheim Peritonitis Index (MPI) 20 ± 6
Injury Severity Score (ISS) 23 ± 20
In-hospital mortality 32/152 (21.1%)
Type of per protocol incision
(midline/transverse/combined, n = 120)
99 (82.5%)/16 (13.3%)/5 (4.1%)
Björck’s classification at the initiation of
OAT
Grade 1A–clean OA (65.8%)
Grade 1B–contaminated OA (34.2%)
Grade 2A–clean OA developing
adherence (0%)
Grade 2B–contaminated OA
developing adherence (0%)
Grade 3–OA complicated by fistula (0%)
Grade 4–frozen OA (0%)
Björck’s classification at the completion
of OAT
Grade 1A–clean OA (83.7%)
Grade 1B–contaminated OA (16.3%)
Grade 2A–clean OA with adherence
(0%)
Grade 2B–contaminated OA with
adherence (0%)
Grade 3–fistula (0%)
Grade 4–frozen abdomen (0%)
In the per-protocol analysis a midline incision was used in 99
patients (82.5%). In 16 patients there was a transverse incision
(13.3%) and in 5 a combined incision (4.1%) was used.
The average duration of the OAT was 13 days (range 1–93
days). The abdomen of 11 patients (9%) was closed within the
next operation. Most patients (24%) needed 1 change of the
temporary closure. It was evenly distributed for 2, 3, 4, and
5–10 changes of the closure, namely 15%. Only four patients
neededmore than 11 operations to close the abdomen (Figure 2).
Considering the different indications for OA therapy trauma
patients had the shortest mean closure time (2.6 days), 7.2 days
for burst abdomen, 12.4 days for peritonitis patients, and 15.1
days for the patients with sepsis.
The overall fascial closure rate in the per-protocol
analysis after VACM in our study population, being our
primary endpoint, was 80% (96 of 120 patients), which
excluded patients who had died during OA treatment. In
the intention-to-treat analysis (including patients that died
during treatment) the fascial closure rate was 63.2% (96
of 152 patients). An anatomical closure (fascial closure +
subcutaneous and skin closure) was immediately performed
in 90 patients (75%). In 6 (5%) the fascia was sutured, but
the superficial layers were closed using NPWT. Only one
patient needed a bilateral component separation to close the
anterior fascia.
The group of patients that needed a short period of OA
management and only 1-2 NPWT changes reached fascial
closure in 80% of cases, while the groups that needed 7–
21 days of OA management did show a closure rate of 78%
(Table 2).
Considering the classification of OA according to Björk, most
patients in our series had a Grade 1A or 1B. We did not observe
any patients with frozen abdomen as all patients had their initial
surgery as well as the decision for OA treatment in our hospital.
During every change of the NPWT, both the abdomen and the
viscera are flushed and gently mobilized, especially at the level of
the abdominal wall. As this happens 2× a week, frozen abdomen
is not an issue. If final fascial closure is not feasible, at the
last change and closure of the abdomen, we replaced the non-
absorbable mesh by a absorbable mesh and skin closure. This did
not cause any fistulae.
Analysis of Non-fascial Closure
When analyzing the determining factors for non-closure of the
fascia, 19 out of 24 patients that could not be closed, started
their initial VACM 3 or more days after the index procedure
with leaving the abdomen open (79.2%). Reasons for not starting
VACM at initial surgery were risk for postoperative bleeding
(n = 14), fear for anastomotic leakage n = 4 and risk for
biliary fistula (n = 1). In those cases a type of Bogota bag
was installed without NPWT nor mesh placement. Only four
out of 24 got their fascia edges closed despite starting late
(20.8%). Out of the patients that were not closable after OA
management, there was a significant difference between patients
started their VACM immediately at the time of initial surgery
(5/96, 5.2%) vs. patients with a late start of their VACM (19/24,
79.2%; p < 0001). Mortality 12 months after closure was 4.2%
(1/24 patients) vs. 3.1% (3/96 patients; p = 1.0). Median length
of hospital stay of the analyzed 120 patients was 54 days
(range: 4–275 days).
Development of Incisional Hernia During
Follow Up
Considering the follow-up of this specific cohort of patients,
an incisional hernia developed in 35.8% of patients considering
the per-protocol analysis; all patients in which fascial closure
could not be achieved (n = 24) developed an incisional hernia,
of which only seven had a mesh repair. The other 17 did not
want their hernia defect repaired (70.8%). Out of the 90 patients
with fascial closure, 19 developed an incisional hernia as well
(21.1%), and 15 had an abdominal wall repair with retromuscular
mesh (78.9%). The median follow-up period of 49 months
(range 6–96 months).
DISCUSSION
The present study analyzed a large patient cohort with OA for
several indications. When treating this type of patients with
necessity for an open abdomen management, time strategy
is of utmost importance, as closure of the abdominal wall,
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FIGURE 2 | Number of VAC changes classified according to EuraHS.
TABLE 2 | Treatment characteristics.
Number of
patients
% p-value
Complete fascial closure
(per-protocol analysis)
96/120 80
Complete fascial closure
(intention-to-treat analysis)
96/152 63.2
Fascial closure rates according to
OA indication
0.01
Trauma 9/10 90.0
Peritonitis 24/29 82.8
Abdominal compartment syndrome 31/38 81.6
Burst abdomen 1/3 33.3
Sepsis 31/40 77.5
Duration of OAT Fascial closure (%) 0.62
<7 days (1–2 reoperations) 50 80
7–21 days (3–6 reoperations) 47 78
>21 days (7 or more reoperations) 23 78
i.e., fascial closure, should be aimed within 10–14 days.
Initial therapy during the first 24–48 h should not only be
focused on adequate edema- and excessive fluid removal as
well as on hemodynamic stabilization. Surgeons should be
thinking about how to handle the abdominal wall, to evaluate
its compliance and finally how to obtain fascial closure. It
is well-know that a non-closed abdominal cavity poses an
increased risk for complications, not in the least entero-
atmospheric fistulae. Closure is mandatory at the earliest
possibility (22).
The EHS clinical expertise guidelines strongly recommended
the use of dynamic closure techniques over other (static)
techniques to achieve best fascial closure rates and low morbidity
and mortality (18).
Our main findings in this analysis emphasize the importance
of a structured treatment plan, initiated early on during
management of the OA since the use of VACM showed high
rates of fascial closure. The absence of initial intra-abdominal
NPWT as well as a delayed start of MMFT, or the combination
of both, were associated with a high risk of non-fascial closure.
Cirocchi et al. also found better outcomes with NPWT when
compared to techniques without NPWT (1). The difference in
fascial closure rates was not significant and emphasizes the fact
that NPWT alone may not be able to sufficiently prevent fascial
lateralization during OA treatment (23). In some reports we see
fascial closure rates drop to 60% or even to 30% in postponed
NPWT/MMFT (24, 25). A recent review specifically focused on
dynamic closure techniques only. The combination of NPWT
and progressive fascial traction to the midline gives an overall
closure rate between 72 and 93% (26). Main reasons for not to
immediately initiate VACM in our study were bleeding/oozing
at first laparotomy, bile leakage after severe liver trauma or
a concomitant bowel anastomosis during the initial surgery.
Traction was also not always applied from the start of OA
as for some patients quick closure was initially expected. As
these patients had significantly less fascial closure achieved
than patients with immediate start of MMFT and NPWT, a
clear message would be to better use a mesh too many than
diminishing the chances for complete fascial closure. Surgeon’s
experience does not play an important role in this decision
making, as both the initial surgery and the decision for OA
management were always performed by a senior surgeon, familiar
with the mesh mediated fascial traction technique.
Another point of attention using the MMFT technique is the
use of a permanent heavy weight, small pore mesh for traction.
We believe this is essential in these indications in which heavy
traction should be applied on the fascial edges. Large pore meshes
are not suitable for this purpose as they are too elastic and will be
torn during the process.
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The distribution of our patient population and the indications
for OA management reflect those commonly found in the
literature: the most frequently reported indications for OA
were peritonitis or sepsis, followed by ACS, and trauma. The
differences in mortality rates most likely reflect differences in
patient population and only to a lesser extent imply a direct
effect of the applied dynamic closure technique. In our study, in-
hospital mortality of 21% was in line with the literature for OA,
which varies between 10 and 45% (16, 27, 28).
There was a difference in fascial closure rates between the
various indications for OA treatment in our series and the highest
rates were observed for trauma patients (90%), which can be
explained by a combination of the need for a short treatment
period and less systemically ill patients, as shown by Montori
et al. (29). In case fascial closure might take longer, there has
been published sparse data on the use of Botulinum Toxin
A (BTA) in OA management by Zielinski and colleagues in
18 patients (30). This toxin functions by blocking the release
of acetylcholine and pain modulators (calcitonin gene–related
peptide and substance P) from the pre-synaptic cholinergic nerve
terminal, resulting in flaccid paralysis and pain modulation.
If this paralysis may diminish lower midline abdominal wall
tension, the rate of primary fascial closure might increase.
However, at the time of life-saving surgical procedures or trauma,
it is neither indicated nor possible to obtain informed consent
from patients. Alternatively, the procedure for injection of BTA
can be performed during a return trip to the OR. The clinical
effect of this paralysis can be demonstrated as early as day 3
after intramuscular injection with maximum effect reached at 2
weeks (31). In the series of Zielinski et al. the primary fascial
closure rate was 83% with a partial fascial closure rate of 6%
and a planned ventral hernia rate of 11%, but no comparative
analysis was performed with patients without BTA injections.
There were no complications related to BTX (29). Surprisingly,
no other reports have been published using this approach since.
Despite all efforts to finally obtain full fascial closure in OA
patients, the longterm follow-up of these patients in terms of
incisional hernia rate is scarce, and rather worrisome (21, 32, 33).
The incidence of incisional hernias ranged from 21% at 21
months to 54% after 5 years of follow-up. The repair rate in these
series differed and was 33 and 42%, respectively. In our series the
incisional hernia rate was, as can be expected, 100% for patients
in which fascial closure could not be obtained, but it is rather
remarkable that only seven out of these 24 patients requested a
hernia repair (29.2%).
Bjarnason and co-workers reported their 1-year follow-up
after MMFT in combination with NPWT and described 66%
of incisional hernias in these patients using CT evaluation (34).
Despite the fact that more patients can be closed after OAT
using fascial traction in combination with NPWT, the focus for
these patients should now more and more be on how to prevent
incisional hernias developing after final fascial closure in this
severely ill patient population. Petersson et al. recently published
a small series in which an onlay mesh was applied early during
treatment by suturing to the fascia in two rows with a 3- to 4-cm
overlap from the midline incision, used for traction and kept for
reinforced permanent closure. A total of 11 patients were treated
with a fascial closure rate of 100% and a 30 days mortality of 0%.
Only two out of nine patients developed a hernia. Neither of the
hernias were symptomatic nor clinically detectable. Therefore,
this reinforced fascial closure might help toward a decreased
long-term incisional hernia rate (35).
Our study has several limitations: in the absence of sufficiently
large numbers of patients, a multivariate analysis has not been
performed to assess the effects of different factors on fascial
closure rates. Secondly, despite the fact that it is an ambispective
dataset, this single center analysis involves OA patients with
different etiologies. This leads to a heterogeneous mixture of
parameters and without multivariate analysis the influence on
fascial closure rate is difficult to estimate.
In conclusion, the analysis of this large cohort of open
abdomen patients confirmed that VACM is an effective and safe
technique and achieves good results regarding delayed fascial
closure. It is important to realize that several factors are key
in achieving best outcomes and are related to early surgical
decision making: 1. Fast start of intra-abdominal NPWT and 2.
implementing fascial traction as soon as possible.
As comparative data considering the different techniques of
dynamic closure are still lacking, NPWT should be used in
combination with dynamic closure techniques and devices to
obtain better insight in how to best treat these cohorts of patients
in the future.
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